Replies to post #35948 on Biotech Values

[ghmm]

So if everyone’s drug works (I know big IF)
Some combination of PEG-Intron + Ribavirin + 950
Vs.
Some combination of Pegasys + Copegyasis + 191 + R1626

Seems it would be a lot to pay and speculation would be the Roche regiment is more potent. Is SGP’s 503034 that much worse (heard they had trouble with non-responders but thought more trial design problem) then 950?